Enrex-A Syrup is a multi-ingredient expectorant and bronchodilator formulation designed to provide symptomatic relief in respiratory conditions characterized by excessive mucus production, cough, and bronchospasm. Each 5ml of syrup contains Ambroxol 15mg, Guaifenesin 50mg, Menthol 2.5mg, and Terbutaline 1.25mg. Ambroxol acts as a mucolytic agent, facilitating the breakdown and clearance of viscous mucus from the respiratory tract, thereby improving airway patency. Guaifenesin serves as an expectorant, promoting the loosening and expulsion of phlegm, which aids in relieving productive cough. Menthol provides a mild local anesthetic and cooling effect, helping to soothe irritated mucous membranes and reduce cough reflex sensitivity. Terbutaline, a selective beta-2 adrenergic receptor agonist, exerts bronchodilatory effects by relaxing bronchial smooth muscle, thus alleviating bronchospasm and improving airflow. Enrex-A Syrup is indicated for the management of acute and chronic bronchitis, asthma exacerbations, and other obstructive airway diseases where mucus hypersecretion and bronchoconstriction coexist. It should be used under medical supervision, particularly in patients with cardiovascular disorders, hypertension, or hypersensitivity to any component. Dosage and duration of therapy should be individualized based on clinical response and patient tolerance.